BNP Paribas Asset Management
MXCT icon

BNP Paribas Asset Management’s MaxCyte MXCT Stock Holding History

BNP Paribas Asset Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.41M Hold
2,773,554
– – ﹤0.01% 995
2026
Q1 		$1.95M Hold
2,773,554
– – ﹤0.01% 1078
2025
Q4 		$4.3M Buy
+2,773,554
New +$4.43M ﹤0.01% 884

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BNP Paribas Asset Management's MXCT Position: Q2 2026 in Review

BNP Paribas Asset Management held its MaxCyte (MXCT) position steady in Q2 2026 at 2,773,554 shares worth $3.41M. The position accounts for ﹤0.01% of the portfolio, ranked #995.

BNP Paribas Asset Management first reported a position in MXCT in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.3M in Q4 2025. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • BNP Paribas Asset Management held 2,773,554 shares of MaxCyte worth $3.41M as of Q2 2026.
  • BNP Paribas Asset Management left its MaxCyte share count unchanged in Q2 2026.
  • MaxCyte made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #995 holding.
  • BNP Paribas Asset Management first reported a position in MaxCyte in Q4 2025 and has held it in 3 quarters since.
  • BNP Paribas Asset Management's MaxCyte position peaked at $4.3M in Q4 2025.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.